Synergy Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Healthcare Conference
April 24 2017 - 8:00AM
Business Wire
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that
the company will present a corporate update at the 42nd Annual
Deutsche Bank Healthcare Conference in Boston on Wednesday, May 3,
2017 at 12:50 p.m. Eastern Time.
A live webcast of the presentation will be accessible through
the Investor Relations section of the company’s website at
www.synergypharma.com. A replay of the webcast will be available on
Synergy’s website for 90 days following the conference.
About Synergy Pharmaceuticals Inc.
Synergy is a biopharmaceutical company focused on the
development and commercialization of novel gastrointestinal (GI)
therapies. The company has pioneered discovery, research and
development efforts on analogs of uroguanylin, a naturally
occurring and endogenous human GI peptide, for the treatment of GI
diseases and disorders. Synergy’s proprietary GI platform includes
one commercial product TRULANCE™ (plecanatide) and a second lead
product candidate, dolcanatide. For more information, please visit
www.synergypharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170424005346/en/
Synergy Pharmaceuticals Inc.Gem Hopkins, 212-584-7610VP,
Investor Relations and Corporate
Communicationsghopkins@synergypharma.com
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Apr 2023 to Apr 2024